SHANDONG BOAN BIOTECH.H 1 Capital Reinvestment Ratio

Latest as of December 2025: 4.22x

SHANDONG BOAN BIOTECH.H 1 capital reinvestment ratio. SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Capital Reinvestment Ratio of 4.22x as of December 2025, meaning it reinvests 4% of its operating cash flow (€64.89 Million) in capital expenditures (€274.05 Million). Check UJ9 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

4.22x

Capex / Operating Cash Flow

Operating Cash Flow

€64.89 Million

EUR

Capital Expenditures

€274.05 Million

EUR

Data as of

Dec 2025

Most recent filing

Capital Reinvestment Ratio of SHANDONG BOAN BIOTECH.H 1 (2025–2025)

Capital reinvestment ratio of SHANDONG BOAN BIOTECH.H 1 from 2025 to 2025. This chart tracks SHANDONG BOAN BIOTECH.H 1's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is SHANDONG BOAN BIOTECH.H 1 growing its equity to track the company's year-over-year net asset growth rate.

SHANDONG BOAN BIOTECH.H 1 Capital Reinvestment Ratio by Year (2025–2025)

SHANDONG BOAN BIOTECH.H 1 capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see cash flow conversion of SHANDONG BOAN BIOTECH.H 1.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change
2025	4.22x	€64.89 Million	€274.05 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow